Rank | Gene Set | Z-score |
---|---|---|
1 | * tricarboxylic acid cycle (GO:0006099) | 7.00935029 |
2 | carnitine shuttle (GO:0006853) | 5.97326208 |
3 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 5.87972771 |
4 | NADH metabolic process (GO:0006734) | 5.70131977 |
5 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 5.64155145 |
6 | sarcomere organization (GO:0045214) | 5.58350320 |
7 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 5.37637554 |
8 | cardiac myofibril assembly (GO:0055003) | 5.36816394 |
9 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 5.30409688 |
10 | fatty acid transmembrane transport (GO:1902001) | 5.27676032 |
11 | regulation of coenzyme metabolic process (GO:0051196) | 5.05226681 |
12 | regulation of cofactor metabolic process (GO:0051193) | 5.05226681 |
13 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.84223513 |
14 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 4.75784484 |
15 | cardiac muscle contraction (GO:0060048) | 4.71931898 |
16 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 4.70502632 |
17 | myofibril assembly (GO:0030239) | 4.68978098 |
18 | carnitine transmembrane transport (GO:1902603) | 4.65042450 |
19 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 4.63946699 |
20 | plasma membrane repair (GO:0001778) | 4.58706858 |
21 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 4.55964754 |
22 | carnitine transport (GO:0015879) | 4.53692197 |
23 | amino-acid betaine transport (GO:0015838) | 4.53692197 |
24 | lysine catabolic process (GO:0006554) | 4.52800526 |
25 | lysine metabolic process (GO:0006553) | 4.52800526 |
26 | actin-myosin filament sliding (GO:0033275) | 4.48841534 |
27 | muscle filament sliding (GO:0030049) | 4.48841534 |
28 | succinate metabolic process (GO:0006105) | 4.48679732 |
29 | regulation of sequestering of triglyceride (GO:0010889) | 4.37989772 |
30 | 2-oxoglutarate metabolic process (GO:0006103) | 4.32559209 |
31 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 4.31678982 |
32 | cell communication by electrical coupling (GO:0010644) | 4.31605694 |
33 | regulation of fatty acid oxidation (GO:0046320) | 4.23845684 |
34 | skeletal muscle contraction (GO:0003009) | 4.23684627 |
35 | cell communication involved in cardiac conduction (GO:0086065) | 4.09993509 |
36 | fatty acid beta-oxidation (GO:0006635) | 4.08804366 |
37 | aspartate family amino acid catabolic process (GO:0009068) | 4.06664137 |
38 | ventricular cardiac muscle cell action potential (GO:0086005) | 4.03627390 |
39 | regulation of sulfur metabolic process (GO:0042762) | 4.00103608 |
40 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.99714047 |
41 | regulation of actin filament-based movement (GO:1903115) | 3.98968052 |
42 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.95502399 |
43 | gluconeogenesis (GO:0006094) | 3.92188193 |
44 | regulation of membrane repolarization (GO:0060306) | 3.86494372 |
45 | cellular potassium ion homeostasis (GO:0030007) | 3.83804475 |
46 | cardiac muscle cell development (GO:0055013) | 3.75947638 |
47 | striated muscle contraction (GO:0006941) | 3.75862492 |
48 | oxaloacetate metabolic process (GO:0006107) | 3.75492492 |
49 | actomyosin structure organization (GO:0031032) | 3.72113191 |
50 | regulation of skeletal muscle contraction (GO:0014819) | 3.64802476 |
51 | actin-mediated cell contraction (GO:0070252) | 3.63788471 |
52 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.61416240 |
53 | cardiac muscle hypertrophy (GO:0003300) | 3.60058652 |
54 | quaternary ammonium group transport (GO:0015697) | 3.58221685 |
55 | hexose biosynthetic process (GO:0019319) | 3.55892919 |
56 | regulation of relaxation of muscle (GO:1901077) | 3.51602394 |
57 | cardiac cell development (GO:0055006) | 3.48951210 |
58 | regulation of cell communication by electrical coupling (GO:0010649) | 3.48671181 |
59 | fructose metabolic process (GO:0006000) | 3.48215845 |
60 | biotin metabolic process (GO:0006768) | 3.47540168 |
61 | acetyl-CoA metabolic process (GO:0006084) | 3.44561028 |
62 | striated muscle hypertrophy (GO:0014897) | 3.43818264 |
63 | fatty acid catabolic process (GO:0009062) | 3.35904344 |
64 | fatty acid oxidation (GO:0019395) | 3.34193083 |
65 | regulation of the force of heart contraction (GO:0002026) | 3.32777890 |
66 | adult heart development (GO:0007512) | 3.30901674 |
67 | monosaccharide biosynthetic process (GO:0046364) | 3.29290879 |
68 | lipid oxidation (GO:0034440) | 3.29027305 |
69 | oxidative phosphorylation (GO:0006119) | 3.28024118 |
70 | * tricarboxylic acid metabolic process (GO:0072350) | 3.26911076 |
71 | regulation of striated muscle contraction (GO:0006942) | 3.26461592 |
72 | positive regulation of fatty acid oxidation (GO:0046321) | 3.24155823 |
73 | muscle contraction (GO:0006936) | 3.22260083 |
74 | heart trabecula formation (GO:0060347) | 3.20867379 |
75 | glycolytic process (GO:0006096) | 3.19195994 |
76 | heart process (GO:0003015) | 3.17430576 |
77 | heart contraction (GO:0060047) | 3.17430576 |
78 | branched-chain amino acid catabolic process (GO:0009083) | 3.16642514 |
79 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.15968802 |
80 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.15286336 |
81 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.14925007 |
82 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 3.13913824 |
83 | creatine metabolic process (GO:0006600) | 3.13372487 |
84 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.12256476 |
85 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.11953772 |
86 | negative regulation of potassium ion transport (GO:0043267) | 3.11352628 |
87 | regulation of sarcomere organization (GO:0060297) | 3.10756468 |
88 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.10238065 |
89 | cardiac muscle cell action potential (GO:0086001) | 3.09797022 |
90 | respiratory electron transport chain (GO:0022904) | 3.08979111 |
91 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.07456027 |
92 | sodium ion export (GO:0071436) | 3.06732586 |
93 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.06182862 |
94 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 3.05897181 |
95 | short-chain fatty acid metabolic process (GO:0046459) | 3.05616421 |
96 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.04216764 |
97 | relaxation of cardiac muscle (GO:0055119) | 3.03952462 |
98 | intracellular lipid transport (GO:0032365) | 3.01599549 |
99 | cellular response to epinephrine stimulus (GO:0071872) | 3.01454466 |
100 | branched-chain amino acid metabolic process (GO:0009081) | 3.00743589 |
101 | detection of calcium ion (GO:0005513) | 3.00712442 |
102 | electron transport chain (GO:0022900) | 2.99619574 |
103 | activation of protein kinase A activity (GO:0034199) | 2.98599849 |
104 | striated muscle adaptation (GO:0014888) | 2.96793479 |
105 | muscle hypertrophy (GO:0014896) | 2.96688638 |
106 | skeletal muscle adaptation (GO:0043501) | 2.96687858 |
107 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.95695290 |
108 | cardiac conduction (GO:0061337) | 2.95690221 |
109 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 2.93726186 |
110 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.93230043 |
111 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.93230043 |
112 | regulation of cardiac muscle cell contraction (GO:0086004) | 2.92627306 |
113 | potassium ion import (GO:0010107) | 2.92295188 |
114 | synaptic vesicle maturation (GO:0016188) | 2.91760825 |
115 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.89652398 |
116 | muscle system process (GO:0003012) | 2.88628893 |
117 | valine metabolic process (GO:0006573) | 2.88565520 |
118 | muscle tissue morphogenesis (GO:0060415) | 2.88428185 |
119 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 2.87903942 |
120 | muscle hypertrophy in response to stress (GO:0003299) | 2.87903942 |
121 | cardiac muscle adaptation (GO:0014887) | 2.87903942 |
122 | actin filament-based movement (GO:0030048) | 2.87182280 |
123 | response to inactivity (GO:0014854) | 2.86093603 |
124 | synaptic vesicle exocytosis (GO:0016079) | 2.86020687 |
125 | positive regulation of synapse maturation (GO:0090129) | 2.85834531 |
126 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.85546583 |
127 | response to epinephrine (GO:0071871) | 2.83600521 |
128 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.80385809 |
129 | cellular sodium ion homeostasis (GO:0006883) | 2.79907398 |
130 | glutamate secretion (GO:0014047) | 2.78965673 |
131 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.73614089 |
132 | potassium ion homeostasis (GO:0055075) | 2.71833173 |
133 | regulation of ATP catabolic process (GO:1903289) | 2.69786812 |
134 | regulation of ATPase activity (GO:0043462) | 2.69786812 |
135 | Golgi transport vesicle coating (GO:0048200) | 2.69485608 |
136 | COPI coating of Golgi vesicle (GO:0048205) | 2.69485608 |
137 | glycogen catabolic process (GO:0005980) | 2.68458471 |
138 | glucan catabolic process (GO:0009251) | 2.66816957 |
139 | cGMP-mediated signaling (GO:0019934) | 2.66224049 |
140 | response to muscle activity (GO:0014850) | 2.66129912 |
141 | response to mercury ion (GO:0046689) | 2.58546740 |
142 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.57946880 |
143 | regulation of heart contraction (GO:0008016) | 2.55476660 |
144 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.54433747 |
145 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.54433747 |
146 | pyruvate metabolic process (GO:0006090) | 2.54365407 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 7.08587430 |
2 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 4.03877559 |
3 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.82745336 |
4 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.76581601 |
5 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.72254959 |
6 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.47077425 |
7 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.47077425 |
8 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.45211163 |
9 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.41149248 |
10 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.25226283 |
11 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.14028616 |
12 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.13155838 |
13 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.06966606 |
14 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.03348319 |
15 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.02446772 |
16 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.93566974 |
17 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.87086114 |
18 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.79571215 |
19 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.76450891 |
20 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.70561304 |
21 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.67901703 |
22 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.66687735 |
23 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.63832850 |
24 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.63545883 |
25 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.62852818 |
26 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.62535476 |
27 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.60099446 |
28 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.59120034 |
29 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.56412662 |
30 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.55689718 |
31 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.54682496 |
32 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.53844850 |
33 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.52937516 |
34 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.52410466 |
35 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.49414798 |
36 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.49353600 |
37 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.47751910 |
38 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.45037156 |
39 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.44829820 |
40 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.44094495 |
41 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.43895871 |
42 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.41555124 |
43 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.41068384 |
44 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.40888023 |
45 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.40563508 |
46 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.39870456 |
47 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.38909458 |
48 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.38208496 |
49 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.36795445 |
50 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.34855750 |
51 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.34855750 |
52 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.33819294 |
53 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.31074574 |
54 | KDM2B_26808549_Chip-Seq_K562_Human | 1.30619384 |
55 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.30087159 |
56 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.29901345 |
57 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.28494077 |
58 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.27526563 |
59 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.27179354 |
60 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.24896156 |
61 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.23442447 |
62 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.23006446 |
63 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.22875288 |
64 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.22398547 |
65 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.21988617 |
66 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.21802104 |
67 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.18100273 |
68 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.17730462 |
69 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.16880284 |
70 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.16801814 |
71 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.16797802 |
72 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.15758350 |
73 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.14897960 |
74 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.14116515 |
75 | SA1_27219007_Chip-Seq_Bcells_Human | 1.13169956 |
76 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.13158709 |
77 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.12974382 |
78 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.12739383 |
79 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.11658518 |
80 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.11522812 |
81 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.11199047 |
82 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.10951616 |
83 | P68_20966046_ChIP-Seq_HELA_Human | 1.08528025 |
84 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.07499705 |
85 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 1.07438264 |
86 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.07321604 |
87 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.06445519 |
88 | * GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.06136892 |
89 | GATA1_19941826_ChIP-Seq_K562_Human | 1.05699184 |
90 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.05603736 |
91 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.04949699 |
92 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 1.04521950 |
93 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.02958609 |
94 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.02728150 |
95 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.02671574 |
96 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.01647944 |
97 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.01585544 |
98 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.00296666 |
99 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 1.00189671 |
100 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.99580994 |
101 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.98898750 |
102 | * BCOR_27268052_Chip-Seq_Bcells_Human | 0.98702068 |
103 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.98054665 |
104 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.97938414 |
105 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97681295 |
106 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.97418851 |
107 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.97382276 |
108 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.97349860 |
109 | MYC_22102868_ChIP-Seq_BL_Human | 0.97218669 |
110 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.96814530 |
111 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.96215556 |
112 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.95804823 |
113 | ATF3_27146783_Chip-Seq_COLON_Human | 0.95603308 |
114 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.94859578 |
115 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 0.94778807 |
116 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.94742762 |
117 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.94359690 |
118 | * ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.93619497 |
119 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.93277191 |
120 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.93190447 |
121 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.92239820 |
122 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.91035138 |
123 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.90839660 |
124 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.90805657 |
125 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.90789819 |
126 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.90507882 |
127 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.90012761 |
128 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.89455935 |
129 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.89451538 |
130 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.88911058 |
131 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.88357110 |
132 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.87679871 |
133 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.86980128 |
134 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.86862078 |
135 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.83547625 |
136 | AR_19668381_ChIP-Seq_PC3_Human | 0.83017954 |
137 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.82711006 |
138 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.81685857 |
139 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.81251167 |
140 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.79685707 |
141 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.79636063 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002837_dystrophic_cardiac_calcinosis | 5.67855396 |
2 | MP0003646_muscle_fatigue | 4.94421031 |
3 | MP0004084_abnormal_cardiac_muscle | 4.45582565 |
4 | MP0000751_myopathy | 4.40323623 |
5 | MP0004215_abnormal_myocardial_fiber | 3.81800405 |
6 | MP0004036_abnormal_muscle_relaxation | 3.50895008 |
7 | MP0004130_abnormal_muscle_cell | 3.40187188 |
8 | MP0005330_cardiomyopathy | 3.24631208 |
9 | MP0005451_abnormal_body_composition | 3.17323345 |
10 | MP0000749_muscle_degeneration | 3.12657514 |
11 | MP0004087_abnormal_muscle_fiber | 2.72350751 |
12 | MP0002972_abnormal_cardiac_muscle | 2.54750684 |
13 | MP0005670_abnormal_white_adipose | 2.50035378 |
14 | MP0005666_abnormal_adipose_tissue | 2.43200690 |
15 | MP0008775_abnormal_heart_ventricle | 2.42591282 |
16 | MP0005620_abnormal_muscle_contractility | 2.39043445 |
17 | MP0003137_abnormal_impulse_conducting | 2.31932380 |
18 | MP0000750_abnormal_muscle_regeneration | 2.16353899 |
19 | MP0002269_muscular_atrophy | 2.15211465 |
20 | MP0005385_cardiovascular_system_phenoty | 2.11470869 |
21 | MP0001544_abnormal_cardiovascular_syste | 2.11470869 |
22 | MP0000747_muscle_weakness | 2.10157613 |
23 | MP0002106_abnormal_muscle_physiology | 2.09301021 |
24 | MP0004145_abnormal_muscle_electrophysio | 2.08708522 |
25 | MP0006138_congestive_heart_failure | 2.08558622 |
26 | MP0004233_abnormal_muscle_weight | 2.06543518 |
27 | MP0004484_altered_response_of | 2.02397602 |
28 | MP0010630_abnormal_cardiac_muscle | 2.02246982 |
29 | MP0006036_abnormal_mitochondrial_physio | 1.99622110 |
30 | MP0004043_abnormal_pH_regulation | 1.84011293 |
31 | MP0000759_abnormal_skeletal_muscle | 1.79794112 |
32 | MP0004185_abnormal_adipocyte_glucose | 1.79742458 |
33 | MP0004085_abnormal_heartbeat | 1.79242304 |
34 | MP0005375_adipose_tissue_phenotype | 1.75567811 |
35 | MP0003221_abnormal_cardiomyocyte_apopto | 1.75490662 |
36 | MP0004859_abnormal_synaptic_plasticity | 1.73915927 |
37 | MP0005369_muscle_phenotype | 1.70027113 |
38 | MP0000013_abnormal_adipose_tissue | 1.62885295 |
39 | MP0005058_abnormal_lysosome_morphology | 1.58788727 |
40 | MP0003879_abnormal_hair_cell | 1.56285461 |
41 | MP0009780_abnormal_chondrocyte_physiolo | 1.45333768 |
42 | MP0002971_abnormal_brown_adipose | 1.44998895 |
43 | MP0002909_abnormal_adrenal_gland | 1.44540989 |
44 | MP0005423_abnormal_somatic_nervous | 1.37688189 |
45 | MP0000003_abnormal_adipose_tissue | 1.37318915 |
46 | MP0008260_abnormal_autophagy | 1.36772916 |
47 | MP0002332_abnormal_exercise_endurance | 1.31823041 |
48 | MP0008961_abnormal_basal_metabolism | 1.31517118 |
49 | MP0002822_catalepsy | 1.24920852 |
50 | MP0003705_abnormal_hypodermis_morpholog | 1.23092672 |
51 | MP0005535_abnormal_body_temperature | 1.19656170 |
52 | MP0000604_amyloidosis | 1.17570702 |
53 | MP0003828_pulmonary_edema | 1.17303243 |
54 | MP0006035_abnormal_mitochondrial_morpho | 1.12634034 |
55 | MP0004510_myositis | 1.08637855 |
56 | MP0005332_abnormal_amino_acid | 1.08375515 |
57 | MP0000920_abnormal_myelination | 1.07570306 |
58 | MP0003075_altered_response_to | 1.07190440 |
59 | MP0003329_amyloid_beta_deposits | 1.03403876 |
60 | MP0002734_abnormal_mechanical_nocicepti | 1.01684419 |
61 | MP0002078_abnormal_glucose_homeostasis | 0.97102035 |
62 | MP0005166_decreased_susceptibility_to | 0.96777360 |
63 | MP0002127_abnormal_cardiovascular_syste | 0.94419956 |
64 | MP0005409_darkened_coat_color | 0.93874572 |
65 | MP0008874_decreased_physiological_sensi | 0.93534699 |
66 | MP0000230_abnormal_systemic_arterial | 0.91763321 |
67 | MP0002234_abnormal_pharynx_morphology | 0.90801892 |
68 | MP0003635_abnormal_synaptic_transmissio | 0.90653226 |
69 | MP0002118_abnormal_lipid_homeostasis | 0.90306829 |
70 | MP0003634_abnormal_glial_cell | 0.90050210 |
71 | MP0004858_abnormal_nervous_system | 0.89884907 |
72 | MP0004270_analgesia | 0.87726384 |
73 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.87388152 |
74 | MP0000266_abnormal_heart_morphology | 0.85056369 |
75 | MP0005623_abnormal_meninges_morphology | 0.85049148 |
76 | MP0003183_abnormal_peptide_metabolism | 0.84981443 |
77 | MP0003191_abnormal_cellular_cholesterol | 0.84078691 |
78 | MP0002108_abnormal_muscle_morphology | 0.80593488 |
79 | MP0005360_urolithiasis | 0.80340340 |
80 | MP0002139_abnormal_hepatobiliary_system | 0.80076073 |
81 | MP0010329_abnormal_lipoprotein_level | 0.79666112 |
82 | MP0005266_abnormal_metabolism | 0.78785325 |
83 | MP0004924_abnormal_behavior | 0.77380345 |
84 | MP0005386_behavior/neurological_phenoty | 0.77380345 |
85 | MP0003950_abnormal_plasma_membrane | 0.76693671 |
86 | MP0002272_abnormal_nervous_system | 0.75740100 |
87 | MP0005165_increased_susceptibility_to | 0.75039789 |
88 | MP0005334_abnormal_fat_pad | 0.71556232 |
89 | MP0008569_lethality_at_weaning | 0.71013234 |
90 | MP0005365_abnormal_bile_salt | 0.70168401 |
91 | MP0005319_abnormal_enzyme/_coenzyme | 0.67781624 |
92 | MP0009046_muscle_twitch | 0.67611997 |
93 | MP0000343_altered_response_to | 0.67093754 |
94 | MP0001765_abnormal_ion_homeostasis | 0.66648299 |
95 | MP0002066_abnormal_motor_capabilities/c | 0.66234065 |
96 | MP0005167_abnormal_blood-brain_barrier | 0.65663350 |
97 | MP0002970_abnormal_white_adipose | 0.65272034 |
98 | MP0003195_calcinosis | 0.63608078 |
99 | MP0005448_abnormal_energy_balance | 0.62926619 |
100 | MP0009745_abnormal_behavioral_response | 0.62482005 |
101 | MP0004147_increased_porphyrin_level | 0.62058782 |
102 | MP0002064_seizures | 0.61870062 |
103 | MP0001502_abnormal_circadian_rhythm | 0.61716556 |
104 | MP0002063_abnormal_learning/memory/cond | 0.61378468 |
105 | MP0009643_abnormal_urine_homeostasis | 0.61249142 |
106 | MP0003567_abnormal_fetal_cardiomyocyte | 0.61057868 |
107 | MP0009115_abnormal_fat_cell | 0.60716146 |
108 | MP0010234_abnormal_vibrissa_follicle | 0.60386327 |
109 | MP0001661_extended_life_span | 0.59989319 |
110 | MP0003880_abnormal_central_pattern | 0.59140379 |
111 | MP0003566_abnormal_cell_adhesion | 0.58496684 |
112 | MP0001756_abnormal_urination | 0.57911550 |
113 | MP0003656_abnormal_erythrocyte_physiolo | 0.57429626 |
114 | MP0001501_abnormal_sleep_pattern | 0.57294956 |
115 | MP0005452_abnormal_adipose_tissue | 0.56169044 |
116 | MP0003279_aneurysm | 0.54743766 |
117 | MP0001849_ear_inflammation | 0.54702359 |
118 | MP0003283_abnormal_digestive_organ | 0.54326897 |
119 | MP0002572_abnormal_emotion/affect_behav | 0.53728210 |
120 | MP0001486_abnormal_startle_reflex | 0.53466785 |
121 | MP0003633_abnormal_nervous_system | 0.52191953 |
122 | MP0000733_abnormal_muscle_development | 0.52058418 |
123 | MP0003806_abnormal_nucleotide_metabolis | 0.51255141 |
124 | MP0005187_abnormal_penis_morphology | 0.50427428 |
125 | MP0005085_abnormal_gallbladder_physiolo | 0.48646477 |
126 | MP0003690_abnormal_glial_cell | 0.48576780 |
127 | MP0009840_abnormal_foam_cell | 0.47989999 |
128 | MP0003045_fibrosis | 0.47790273 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Sudden death (HP:0001699) | 6.04126815 |
2 | Nemaline bodies (HP:0003798) | 5.60649359 |
3 | Exercise-induced myalgia (HP:0003738) | 5.52386069 |
4 | Myoglobinuria (HP:0002913) | 5.45566850 |
5 | Exercise-induced muscle cramps (HP:0003710) | 4.99187446 |
6 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 4.72080632 |
7 | Ventricular tachycardia (HP:0004756) | 4.51321322 |
8 | Calf muscle hypertrophy (HP:0008981) | 4.44926326 |
9 | Distal lower limb muscle weakness (HP:0009053) | 4.25228294 |
10 | Muscle fiber splitting (HP:0003555) | 4.19357195 |
11 | Atrial fibrillation (HP:0005110) | 4.15818402 |
12 | Muscle hypertrophy of the lower extremities (HP:0008968) | 4.12347219 |
13 | Myopathic facies (HP:0002058) | 4.05251663 |
14 | Bundle branch block (HP:0011710) | 4.01407558 |
15 | Rhabdomyolysis (HP:0003201) | 3.97312091 |
16 | Primary atrial arrhythmia (HP:0001692) | 3.89930834 |
17 | Hyporeflexia of lower limbs (HP:0002600) | 3.88498796 |
18 | Abnormality of the calf musculature (HP:0001430) | 3.83967802 |
19 | Difficulty running (HP:0009046) | 3.80079717 |
20 | Ketoacidosis (HP:0001993) | 3.76071530 |
21 | Supraventricular tachycardia (HP:0004755) | 3.73884050 |
22 | Supraventricular arrhythmia (HP:0005115) | 3.68148675 |
23 | Lipoatrophy (HP:0100578) | 3.62535093 |
24 | Palpitations (HP:0001962) | 3.62499882 |
25 | Syncope (HP:0001279) | 3.54673519 |
26 | Subaortic stenosis (HP:0001682) | 3.52518826 |
27 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.52518826 |
28 | Hypoglycemic coma (HP:0001325) | 3.51440652 |
29 | Right ventricular cardiomyopathy (HP:0011663) | 3.50223630 |
30 | Prolonged QT interval (HP:0001657) | 3.37841185 |
31 | Ventricular fibrillation (HP:0001663) | 3.31523093 |
32 | Asymmetric septal hypertrophy (HP:0001670) | 3.30301765 |
33 | Distal lower limb amyotrophy (HP:0008944) | 3.24972047 |
34 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.23729891 |
35 | Increased connective tissue (HP:0009025) | 3.23167025 |
36 | Ventricular arrhythmia (HP:0004308) | 3.22348205 |
37 | Dilated cardiomyopathy (HP:0001644) | 3.20479447 |
38 | Heart block (HP:0012722) | 3.16537282 |
39 | Hyperglycinuria (HP:0003108) | 3.15167541 |
40 | Atrioventricular block (HP:0001678) | 3.14836686 |
41 | EMG: myopathic abnormalities (HP:0003458) | 3.12294072 |
42 | Rimmed vacuoles (HP:0003805) | 3.06744764 |
43 | Pheochromocytoma (HP:0002666) | 3.05261986 |
44 | Abnormality of the foot musculature (HP:0001436) | 3.01870779 |
45 | Foot dorsiflexor weakness (HP:0009027) | 2.96397637 |
46 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.95526713 |
47 | Dicarboxylic aciduria (HP:0003215) | 2.95526713 |
48 | Abnormal atrioventricular conduction (HP:0005150) | 2.94460407 |
49 | Ketosis (HP:0001946) | 2.92237898 |
50 | Myotonia (HP:0002486) | 2.89277107 |
51 | Hepatic necrosis (HP:0002605) | 2.85371637 |
52 | Dysmetric saccades (HP:0000641) | 2.80163945 |
53 | Muscle stiffness (HP:0003552) | 2.76654847 |
54 | Lower limb amyotrophy (HP:0007210) | 2.74630757 |
55 | Conjunctival hamartoma (HP:0100780) | 2.71939254 |
56 | Distal arthrogryposis (HP:0005684) | 2.68992576 |
57 | Frequent falls (HP:0002359) | 2.64866389 |
58 | Increased muscle lipid content (HP:0009058) | 2.64405438 |
59 | Neuroendocrine neoplasm (HP:0100634) | 2.61252089 |
60 | Ankle clonus (HP:0011448) | 2.59026084 |
61 | Type 1 muscle fiber predominance (HP:0003803) | 2.58550749 |
62 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.57727882 |
63 | Abnormality of glycine metabolism (HP:0010895) | 2.57727882 |
64 | Abnormal EKG (HP:0003115) | 2.54096140 |
65 | Round ear (HP:0100830) | 2.53460034 |
66 | Difficulty climbing stairs (HP:0003551) | 2.51765504 |
67 | Increased variability in muscle fiber diameter (HP:0003557) | 2.51589580 |
68 | Hamartoma of the eye (HP:0010568) | 2.50500857 |
69 | Myokymia (HP:0002411) | 2.49667862 |
70 | Abnormal gallbladder physiology (HP:0012438) | 2.41754905 |
71 | Cholecystitis (HP:0001082) | 2.41754905 |
72 | Hyperammonemia (HP:0001987) | 2.41373874 |
73 | Bulbar palsy (HP:0001283) | 2.39210751 |
74 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.38378127 |
75 | Generalized aminoaciduria (HP:0002909) | 2.37443704 |
76 | Ragged-red muscle fibers (HP:0003200) | 2.29316541 |
77 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.25944972 |
78 | Ulnar deviation of the wrist (HP:0003049) | 2.25876273 |
79 | Neoplasm of the adrenal gland (HP:0100631) | 2.24444967 |
80 | Acute encephalopathy (HP:0006846) | 2.18823307 |
81 | Muscle fiber inclusion bodies (HP:0100299) | 2.16813431 |
82 | Hepatocellular necrosis (HP:0001404) | 2.16330080 |
83 | Gout (HP:0001997) | 2.12500682 |
84 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.11442389 |
85 | Left ventricular hypertrophy (HP:0001712) | 2.08625366 |
86 | Areflexia of lower limbs (HP:0002522) | 2.08202303 |
87 | Hyperalaninemia (HP:0003348) | 2.08116063 |
88 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.08116063 |
89 | Abnormality of alanine metabolism (HP:0010916) | 2.08116063 |
90 | Acute necrotizing encephalopathy (HP:0006965) | 2.06418481 |
91 | Cerebral edema (HP:0002181) | 2.06147307 |
92 | Proximal tubulopathy (HP:0000114) | 2.02810149 |
93 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.02322189 |
94 | Lymphangioma (HP:0100764) | 2.00465314 |
95 | Limb-girdle muscle atrophy (HP:0003797) | 1.99757800 |
96 | Facial diplegia (HP:0001349) | 1.96756207 |
97 | Neurofibrillary tangles (HP:0002185) | 1.96555621 |
98 | Generalized muscle weakness (HP:0003324) | 1.95500274 |
99 | Neck muscle weakness (HP:0000467) | 1.94551013 |
100 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.94539323 |
101 | Lactic acidosis (HP:0003128) | 1.94254362 |
102 | Central scotoma (HP:0000603) | 1.90531271 |
103 | Abnormality of glycolysis (HP:0004366) | 1.90410608 |
104 | Increased serum pyruvate (HP:0003542) | 1.90410608 |
105 | Cholelithiasis (HP:0001081) | 1.90195720 |
106 | Distal upper limb amyotrophy (HP:0007149) | 1.89884243 |
107 | Upper limb amyotrophy (HP:0009129) | 1.89884243 |
108 | Large for gestational age (HP:0001520) | 1.88825781 |
109 | Increased intramyocellular lipid droplets (HP:0012240) | 1.88342649 |
110 | Esophageal neoplasm (HP:0100751) | 1.88120748 |
111 | Neoplasm of head and neck (HP:0012288) | 1.88120748 |
112 | Sudden cardiac death (HP:0001645) | 1.87806623 |
113 | Axonal loss (HP:0003447) | 1.87034096 |
114 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.86024769 |
115 | Progressive muscle weakness (HP:0003323) | 1.84865707 |
116 | EMG: neuropathic changes (HP:0003445) | 1.84604421 |
117 | Cerebral inclusion bodies (HP:0100314) | 1.83386235 |
118 | Tinnitus (HP:0000360) | 1.83300759 |
119 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.81782713 |
120 | Calcaneovalgus deformity (HP:0001848) | 1.79560892 |
121 | Rapidly progressive (HP:0003678) | 1.78763148 |
122 | Spinal rigidity (HP:0003306) | 1.78527715 |
123 | Supranuclear gaze palsy (HP:0000605) | 1.77325835 |
124 | Progressive macrocephaly (HP:0004481) | 1.77064527 |
125 | Increased purine levels (HP:0004368) | 1.75253917 |
126 | Hyperuricemia (HP:0002149) | 1.75253917 |
127 | Scapular winging (HP:0003691) | 1.73749501 |
128 | Oligomenorrhea (HP:0000876) | 1.72523447 |
129 | Metabolic acidosis (HP:0001942) | 1.72466448 |
130 | Gowers sign (HP:0003391) | 1.72198188 |
131 | Resting tremor (HP:0002322) | 1.71763829 |
132 | Tetraplegia (HP:0002445) | 1.67870115 |
133 | Steppage gait (HP:0003376) | 1.67325654 |
134 | Abnormal gallbladder morphology (HP:0012437) | 1.62825409 |
135 | Achilles tendon contracture (HP:0001771) | 1.59343016 |
136 | Neuronal loss in central nervous system (HP:0002529) | 1.57205315 |
137 | Slow progression (HP:0003677) | 1.55136126 |
138 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.54051593 |
139 | Hammertoe (HP:0001765) | 1.54019895 |
140 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.51688014 |
141 | Deformed tarsal bones (HP:0008119) | 1.49150310 |
142 | Depression (HP:0000716) | 1.49059405 |
143 | Reticulocytosis (HP:0001923) | 1.49016516 |
144 | Diaphragmatic weakness (HP:0009113) | 1.48450517 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TRIB3 | 4.15924728 |
2 | PDK4 | 3.98265006 |
3 | PDK3 | 3.98265006 |
4 | TTN | 3.93795257 |
5 | LMTK2 | 3.61062513 |
6 | PHKG1 | 3.28995989 |
7 | PHKG2 | 3.28995989 |
8 | PKN2 | 3.18817832 |
9 | NEK1 | 3.04969066 |
10 | BCKDK | 2.89843881 |
11 | OBSCN | 2.82828061 |
12 | PRPF4B | 2.63761327 |
13 | PDK2 | 2.30013035 |
14 | DMPK | 1.95394892 |
15 | MYLK | 1.94190448 |
16 | PINK1 | 1.88999232 |
17 | PRKD3 | 1.78355929 |
18 | WNK4 | 1.72260152 |
19 | TESK1 | 1.68241221 |
20 | ERN1 | 1.66657822 |
21 | ARAF | 1.56592328 |
22 | RIPK1 | 1.55726102 |
23 | LIMK1 | 1.40485891 |
24 | UHMK1 | 1.31738048 |
25 | PIK3CA | 1.25824117 |
26 | PAK3 | 1.22474857 |
27 | PAK6 | 1.21377850 |
28 | MAP3K7 | 1.21149526 |
29 | MAP3K11 | 1.19439583 |
30 | KSR2 | 1.19352470 |
31 | STK38 | 1.16341666 |
32 | TESK2 | 1.13498434 |
33 | CAMK1D | 1.10597427 |
34 | TIE1 | 1.09315801 |
35 | SIK1 | 1.07292892 |
36 | SMG1 | 1.07079475 |
37 | MAP3K9 | 1.05577459 |
38 | EPHA4 | 1.04687560 |
39 | PDGFRA | 1.03527867 |
40 | CCNB1 | 0.99620887 |
41 | PRKAA1 | 0.98068901 |
42 | STK24 | 0.96802256 |
43 | MAP3K4 | 0.96692077 |
44 | ILK | 0.94973388 |
45 | CAMK1G | 0.93831151 |
46 | PRKD1 | 0.92653455 |
47 | CAMK2B | 0.91071327 |
48 | TAOK2 | 0.85679463 |
49 | FGFR4 | 0.85660737 |
50 | MAP2K4 | 0.85373211 |
51 | PDPK1 | 0.85282871 |
52 | NTRK3 | 0.83323511 |
53 | PRKCH | 0.82762737 |
54 | PRKAA2 | 0.82665260 |
55 | CAMKK1 | 0.82520994 |
56 | WNK1 | 0.81883997 |
57 | CDC42BPA | 0.81673734 |
58 | ICK | 0.80054755 |
59 | MUSK | 0.77838070 |
60 | CAMK2D | 0.77690095 |
61 | PDK1 | 0.77605522 |
62 | SGK3 | 0.77507704 |
63 | NEK9 | 0.77425150 |
64 | ROCK1 | 0.77049021 |
65 | DAPK2 | 0.76365028 |
66 | WNK3 | 0.75602397 |
67 | MAPK12 | 0.74991427 |
68 | MAPK4 | 0.74899593 |
69 | RET | 0.74282697 |
70 | RIPK4 | 0.74167053 |
71 | PIM2 | 0.73088279 |
72 | MAP3K13 | 0.69718236 |
73 | MARK2 | 0.69469459 |
74 | PRKG2 | 0.69032894 |
75 | MINK1 | 0.68057805 |
76 | INSRR | 0.66016540 |
77 | PTK6 | 0.65969567 |
78 | DYRK1B | 0.63886095 |
79 | TAOK1 | 0.63734115 |
80 | CDK15 | 0.61068223 |
81 | MARK1 | 0.60951259 |
82 | CDK11A | 0.59272250 |
83 | DAPK3 | 0.59136868 |
84 | EPHA3 | 0.57265917 |
85 | CAMK1 | 0.56550175 |
86 | CDK18 | 0.55997034 |
87 | SGK494 | 0.54367495 |
88 | SGK223 | 0.54367495 |
89 | CAMK4 | 0.53568270 |
90 | TBK1 | 0.53492953 |
91 | EEF2K | 0.53223203 |
92 | DAPK1 | 0.51950546 |
93 | NTRK1 | 0.51691214 |
94 | KSR1 | 0.51631596 |
95 | LATS2 | 0.51415468 |
96 | PRKACG | 0.50753423 |
97 | STK39 | 0.50506661 |
98 | MAPK10 | 0.50421143 |
99 | MAP3K5 | 0.50387054 |
100 | CDK14 | 0.50004129 |
101 | EPHB1 | 0.49747109 |
102 | PTK2B | 0.49515291 |
103 | OXSR1 | 0.48708353 |
104 | MAP2K1 | 0.47297005 |
105 | CDK5 | 0.47270249 |
106 | BRAF | 0.47065756 |
107 | MAPKAPK3 | 0.46999255 |
108 | PKN1 | 0.46380679 |
109 | MAPK7 | 0.45628578 |
110 | CAMK2A | 0.44717482 |
111 | TYRO3 | 0.44412095 |
112 | DDR2 | 0.44356825 |
113 | ROCK2 | 0.44335161 |
114 | ALK | 0.43810164 |
115 | RPS6KA2 | 0.42923788 |
116 | FER | 0.42487690 |
117 | SGK2 | 0.42360235 |
118 | STK11 | 0.41424936 |
119 | STK38L | 0.41175717 |
120 | PIK3CG | 0.41092848 |
121 | MOS | 0.40153266 |
122 | MST1R | 0.40096175 |
123 | AKT2 | 0.39352622 |
124 | SGK1 | 0.39296568 |
125 | MAP3K3 | 0.38966327 |
126 | NTRK2 | 0.37593277 |
127 | PRKACB | 0.37535676 |
128 | FLT3 | 0.36763386 |
129 | RPS6KA3 | 0.36288064 |
130 | MTOR | 0.34106361 |
131 | BMX | 0.33282896 |
132 | CAMK2G | 0.33203015 |
133 | NME1 | 0.31815760 |
134 | PRKACA | 0.31222149 |
135 | MAP2K3 | 0.30437663 |
136 | LRRK2 | 0.29276389 |
137 | MAP3K1 | 0.27821582 |
138 | MAPK11 | 0.26482334 |
139 | SCYL2 | 0.25443358 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 5.75689885 |
2 | * 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.81140910 |
3 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.61527989 |
4 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.06300998 |
5 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.72151502 |
6 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.68064093 |
7 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.59964094 |
8 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.53899054 |
9 | * Carbon metabolism_Homo sapiens_hsa01200 | 2.46581332 |
10 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.21843978 |
11 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.12475293 |
12 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.08721596 |
13 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.97529428 |
14 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.92168330 |
15 | * Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.72523743 |
16 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.70895659 |
17 | Parkinsons disease_Homo sapiens_hsa05012 | 1.64633102 |
18 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.58963783 |
19 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.56792479 |
20 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.53110388 |
21 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.50457035 |
22 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.47591672 |
23 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.38294444 |
24 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.38252117 |
25 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.38108754 |
26 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.36857410 |
27 | Alzheimers disease_Homo sapiens_hsa05010 | 1.25138394 |
28 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.22506981 |
29 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.20625470 |
30 | * Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.17325423 |
31 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.09930989 |
32 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.08885108 |
33 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.07980148 |
34 | Histidine metabolism_Homo sapiens_hsa00340 | 1.06105004 |
35 | Insulin resistance_Homo sapiens_hsa04931 | 1.04322040 |
36 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.03374116 |
37 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.02168013 |
38 | Prion diseases_Homo sapiens_hsa05020 | 1.01954307 |
39 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.01718097 |
40 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.99727712 |
41 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.97132624 |
42 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.95900979 |
43 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.95075921 |
44 | Huntingtons disease_Homo sapiens_hsa05016 | 0.89452945 |
45 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.87433579 |
46 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.85866801 |
47 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.85166708 |
48 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.84526955 |
49 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.81401515 |
50 | Other glycan degradation_Homo sapiens_hsa00511 | 0.81062193 |
51 | Insulin secretion_Homo sapiens_hsa04911 | 0.80918124 |
52 | Lysine degradation_Homo sapiens_hsa00310 | 0.76838217 |
53 | Circadian entrainment_Homo sapiens_hsa04713 | 0.76641514 |
54 | Bile secretion_Homo sapiens_hsa04976 | 0.76636278 |
55 | Renin secretion_Homo sapiens_hsa04924 | 0.76599466 |
56 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.74798991 |
57 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.74197134 |
58 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.71982115 |
59 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.70608513 |
60 | Mineral absorption_Homo sapiens_hsa04978 | 0.70030155 |
61 | Olfactory transduction_Homo sapiens_hsa04740 | 0.69228742 |
62 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.69191078 |
63 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.69008839 |
64 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.68992823 |
65 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.67871621 |
66 | Peroxisome_Homo sapiens_hsa04146 | 0.67787232 |
67 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.67556212 |
68 | Salivary secretion_Homo sapiens_hsa04970 | 0.66425908 |
69 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.65871193 |
70 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.65342740 |
71 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.63620658 |
72 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.63157428 |
73 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.61706255 |
74 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.61689998 |
75 | Long-term potentiation_Homo sapiens_hsa04720 | 0.61626931 |
76 | GABAergic synapse_Homo sapiens_hsa04727 | 0.60771437 |
77 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.58910161 |
78 | Viral myocarditis_Homo sapiens_hsa05416 | 0.56082267 |
79 | Galactose metabolism_Homo sapiens_hsa00052 | 0.54184063 |
80 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.53673536 |
81 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.51861755 |
82 | Sulfur relay system_Homo sapiens_hsa04122 | 0.50798173 |
83 | Cocaine addiction_Homo sapiens_hsa05030 | 0.50085048 |
84 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.49625897 |
85 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.48448052 |
86 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.48190385 |
87 | Morphine addiction_Homo sapiens_hsa05032 | 0.48178164 |
88 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.47557568 |
89 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.46609410 |
90 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.46292483 |
91 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.45535105 |
92 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.44039864 |
93 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.43941557 |
94 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.43879150 |
95 | Gap junction_Homo sapiens_hsa04540 | 0.42850127 |
96 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.42407278 |
97 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.40635877 |
98 | Focal adhesion_Homo sapiens_hsa04510 | 0.39778867 |
99 | Tight junction_Homo sapiens_hsa04530 | 0.39391170 |
100 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.38078474 |
101 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.37853459 |
102 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.37508093 |
103 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.35300749 |
104 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.34945891 |
105 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.34557934 |
106 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.34533502 |
107 | Melanogenesis_Homo sapiens_hsa04916 | 0.33057277 |
108 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.32305129 |
109 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.29926742 |
110 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.29418527 |
111 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.29300670 |
112 | Glioma_Homo sapiens_hsa05214 | 0.28998609 |
113 | Circadian rhythm_Homo sapiens_hsa04710 | 0.25648949 |
114 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.23317997 |
115 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.23248522 |
116 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.20939236 |
117 | Taste transduction_Homo sapiens_hsa04742 | 0.20708057 |
118 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.20224036 |
119 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.19867053 |
120 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.19244607 |